Full Text

Turn on search term navigation

© 2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:  http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Objectives

To assess the seroprevalence of infection-acquired SARS-CoV-2 and the mental health of school/daycare staff in the months after reopening of schools in Montreal, Quebec (Canada) in the Fall of 2020 and whether these varied by school and participant characteristics.

Design

A cross-sectional design based on a convenience sample of schools/daycares and staff was used as the originally planned longitudinal design was no longer feasible due to obstacles in recruitment, for example, teacher’s strike.

Setting

Forty-nine schools/daycares in four Montreal neighbourhoods from March to October 2021.

Participants

Three-hundred and sixty-two participants completed both questionnaires and serology tests.

Primary and secondary outcome measures

SARS-CoV-2 seroprevalence and prevalence of anxiety, depression, resilience and burnout/emotional exhaustion.

Results

The seroprevalence estimate made representative to the Quebec population of educators was 8.6% (95% CI 5.2 to 13.0). The adjusted seroprevalence in high school was 20% that of elementary school (aRR=0.20, 95% CI 0.07 to 0.58). Thirty per cent of seropositive staff were exposed to a household member with confirmed COVID-19. Prevalence of high emotional exhaustion/burnout was 35%, 44% and 53% in daycare, elementary school and high school staff, respectively. However, moderate/severe anxiety and depression and low resilience did not exceed 18%. After adjusting for confounders, being very afraid of catching COVID-19 at school was associated with moderate–severe anxiety, moderate–severe depression and high emotional exhaustion (aRR=4.4, 95% CI 2.2 to 8.9; aRR=2.8, 95% CI 1.5 to 5.4; aRR=2.2, 95% CI 1.6 to 3.0, respectively).

Conclusion

The seroprevalence, anxiety and depression among school/daycare staff were comparable to the reported levels in the adult population of Quebec. The prevalence of emotional exhaustion/burnout was high across all school levels and exceeding the average across all occupations in the USA and in teachers in Germany.

Details

Title
SARS-CoV-2 seroprevalence and mental health of school staff: a cross-sectional study of schools from four areas of Montreal, Quebec in 2021
Author
Charland, Katia 1 ; Pannunzio, Matteo 2 ; Greenspan-Ardman, Eleanor 2 ; Saucier, Adrien 1 ; Pierce, Laura 1 ; Hamelin, Marie-Eve 3 ; Margot Barbosa Da Torre 1 ; Carbonneau, Julie 3 ; Nguyen, Cat Tuong 4 ; De Serres, Gaston 5 ; Papenburg, Jesse 6 ; Boivin, Guy 3 ; Quach, Caroline 7 ; Zinszer, Kate 1   VIAFID ORCID Logo 

 Université de Montréal, Montréal, Québec, Canada; Centre de recherche en santé publique, Montréal, Québec, Canada 
 McGill University, Montréal, Québec, Canada 
 CHU de Québec-Université Laval, Québec, Québec, Canada 
 Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada 
 Institut national de santé publique du Québec, Québec, Québec, Canada 
 McGill University Health Centre, Montréal, Québec, Canada 
 Université de Montréal, Montréal, Québec, Canada; Sainte-Justine University Hospital Research Centre, Montréal, Québec, Canada 
First page
e081838
Section
Epidemiology
Publication year
2024
Publication date
2024
Publisher
BMJ Publishing Group LTD
e-ISSN
20446055
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3101279138
Copyright
© 2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:  http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.